Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of the Fully Human Anti-tetanus Toxin Monoclonal Antibody A82 / B86 Injection Combination Formulation

Conditions: Clostridium Tetanus Interventions: Drug: Human anti-tetanus toxin monoclonal antibody A82 / B86 injection combination preparation; Drug: Tetanus human immunoglobulin (HTIG); Drug: Whole-human anti-tetanus toxin monoclonal antibody A82 / B86 injection placebo; Biological: Adsorbed tetanus vaccine (TT) Sponsors: Changchun BCHT Biotechnology Co.; The First Affiliated Hospital of Yunnan University of Traditional Chinese Medicine; Anning City First People ' s Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials